Merck gets positive EU CHMP opinion for Keytruda plus Chemotherapy as first-line treatment for adult patients with unresectable non-eithelioid Malignant Pleural Mesothelioma Ruchika Sharma19 Nov 2024 2:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the European Medicines Agency's Committee for Medicinal...
USFDA nod to Merck KEYTRUDA plus Pemetrexed, Platinum Chemotherapy for Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma Ruchika Sharma23 Sept 2024 7:26 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S.Food and Drug Administration (FDA) has approved KEYTRUDA,...
KEYTRUDA plus chemotherapy improves overall survival versus chemotherapy alone to treat advanced malignant pleural mesothelioma: Merck Ruchika Sharma13 March 2023 2:27 PM ISTMalignant mesothelioma is a type of cancer that starts in the linings of certain parts of the body, including the chest, abdomen, heart and testicles.
FDA Approves Drug Combo for treatment of malignant pleural mesothelioma Hina Zahid2 Oct 2020 6:30 PM ISTThe U.S. Food and Drug Administration approved Opdivo (nivolumab) in combination with Yervoy (ipilimumab) for the first-line treatment of adults with...
Near-infrared photoimmunotherapy new therapy for malignant lung cancer Hina Zahid22 Jun 2020 6:59 PM ISTMalignant pleural mesothelioma (MPM) has extremely limited treatment despite a poor prognosis. Researchers have found a new targeted therapy which is...
